Reference no: EM133624667
Discussion Post: Insomnia Disorder in Older Adults
Prescribing for Older Adults and Pregnant Women
After assessing and diagnosing a patient, PMHNPs must take into consideration special characteristics of the patient before determining an appropriate course of treatment. For pharmacological treatments that are not FDA-approved for a particular use or population, off-label use may be considered when the potential benefits could outweigh the risks.
In this Discussion, you will investigate a specific disorder and determine potential appropriate treatments for when it occurs in an older adult or pregnant woman.
To Prepare
Choose one of the two following specific populations: in this case older adults. Then, select a specific disorder from the DSM-5-TR in this caseInsomnia Disorders DSM-5-TR F51.01
Research evidence-based treatments for Insomnia Disorder in older adults. You will need to recommend one FDA-approved drug, one non-FDA-approved "off-label" drug, and one nonpharmacological intervention for treating the disorder in that population.
Task
Question I. Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating your chosen disorder in older.
Question II. Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?
Question III. Explain whether clinical practice guidelines exist for Insomnia Disorder in older adults, and if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.
Question IV. Support your reasoning with at least three current, credible scholarly resources, one each on the FDA-approved drug, the off-label, and a nonpharmacological intervention for the disorder.